Master's thesis of Monika Štimac, carried out under the supervision of dr. Maja Čemažar was dedicated to optimisation of staining the blood vessels in mouse tumors. Development of this method is a prerequisite for validation of antitumor effectiveness of antiangiogenic therapies, including gene therapies, that target tumor vasculature. In the master thesis, the optimization and validation of the method for staining of blood vessels in different tumors following anti-angiogenic gene therapy with RNA molecules against endoglin that is a coreceptor of TGF-beta, which expression is specifically increased in the activated blood vessels, was determined.
D.10 Educational activities
COBISS.SI-ID: 1344891